Brief: Amneal Reports Third Quarter 2024 Financial Results
08/11/2024 11:06
Nov 8 (Reuters) - Amneal Pharmaceuticals Inc AMRX.O :
* AMNEAL REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS
* AMNEAL PHARMA: AFFIRMS 2024 FULL YEAR GUIDANCE
* AMNEAL PHARMA: Q3 ADJUSTED EPS $0.16
* AMNEAL PHARMA: Q3 NET REVENUE $702 MILLION
* Q3 EARNINGS PER SHARE VIEW $0.14, REVENUE VIEW $696.8
MILLION --
LSEG IBES DATA
Source text: ID:nBw8F6t9ha
Further company coverage: AMRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amneal Pharmaceuticals
See all newsFocus: US progesterone supplies tighten as menopause treatment demand grows
U.S. STOCKS ON THE MOVE-Chipotle Mexican Grill, J.B. Hunt, ABM Industries
U.S. STOCKS ON THE MOVE-G-III Apparel, Amneal Pharmaceuticals, BioCardia
U.S. STOCKS ON THE MOVE-Lululemon, Cooper Companies, Cypherpunk Technologies
Amneal Pharma up after Parkinson’s drug shows benefit in late-stage study